The NIH has awarded the UNC HIV Cure Center and Cell Microsystems a Small Business Innovation and Research contract to develop an automated platform to quantify the latent HIV reservoir, a key step in finding a cure for the virus.
UNC researchers say the results from the multi-site phase 2 and 3 trials of brexanolone injection are not only promising, but could change the way postpartum depression is treated.
UNC School of Medicine researchers have identified mutations to the bacterium Neisseria gonnorrhoeae that enable resistance to ceftriaxone that could lead to the global spread of ceftriaxone-resistant “superbug” strains.
UNC School of Medicine researchers discovered a structure on viruses that makes them better at crossing from the bloodstream into the brain – a key factor for administering gene therapies at lower doses for treating brain and spinal disorders. Experiments also showed decreased liver toxicity.
In a study published in the International Journal of Cancer, researchers analyzed health indicators for children born to young breast cancer survivors in North Carolina.
CF researchers have now shown that the lungs’ bacterial population changes in the first few years of life as respiratory infections and inflammation set in. This research offers a way to predict the onset of lung disease and suggests a larger role for preventive therapies, such as hypertonic saline.
Researchers analyzed the impact of one viral social media post in generating awareness about skin cancer.
Researchers present their preliminary results from the ongoing phase II trial of chemotherapy and pembrolizumab in relapsed or refractory acute myeloid leukemia at the 59th American Society of Hematology Annual Meeting in Atlanta on Saturday, Dec. 9.
Researchers report at the 59th Annual American Society for Hematology Annual Meeting in Atlanta on Saturday, Dec. 9, that they were able to validate their approach for predicting markers – called minor histocompatibility antigens – in a group of patients with blood cancers.
UNC and NC State researchers have developed artificial beta cells that automatically release insulin into the bloodstream when glucose levels rise. This work was done in lab experiments but could lead to a much more patient-friendly treatment than injections.
A study led by UNC Lineberger Comprehensive Cancer Center researchers found that preference for preserving sexual function was not strongly reflected in the treatment choices of men with low-risk prostate cancer.
The UNC Center for Health Innovation is included in a new list of 58 Hospitals and Health Systems with Innovation Programs, published today by Becker’s Hospital Review.
During head injury, a common problem is damage to axons – long stalks that grow out of the bodies of neurons. After a strong jolt to the head, axons can break or swiftly degenerate. UNC’s Anne Taylor and colleagues have revealed new molecular details of this and a path toward repairing axons.
UNC-Chapel Hill has a new study in JAMA that challenges long-held practices of testing AMH and FSH levels to predict reproductive potential.
Researchers report in JAMA Dermatology that surgical treatment delays – defined as surgery that occurred more than six weeks after diagnosis – were common. Medicaid patients were 36 percent more likely than private insurance patients to experience delays.
Preliminary findings presented at this year’s American Society for Radiation Oncology Annual Meeting suggest a genetic test for HPV16 in the blood could be useful to help assess risk for patients, and could help identify patients suitable for lower treatment doses.
UNC School of Medicine cardiologist Anil Gehi, MD, will use a $1.7 million grant from the Bristol-Myers Squibb Foundation to further innovate a care model, launched in 2015, that reduced hospitalizations for patients with atrial fibrillation (Afib) presenting in the emergency room by more than 30 percentage points in its first year.